|By Jim Montalto, News Editor|
The latest Infectious Diseases in Corrections Report goes back to the basics as it covers hepatitis B virus (HBV), along with its transmission, prevention, diagnosis, and treatment. The late winter/early spring edition also covers aspects corrections professionals should consider when HBV is in their facility.
After reviewing HBV’s transmission process and the natural history of the infection, IDCR’s lead article, An Approach To Hepatitis B Virus In The Correctional Setting by Jennifer Cocohoba, assistant clinical professor at the University of California San Francisco School of Pharmacy, and Joseph Bick, chief deputy of clinical services at the California Department of Corrections, discusses targets of acute cases and prevention opportunities;
The initial evaluation of a patient who has chronic HBV should include a complete history and physical examination. Blood testing should include a complete blood count with platelets, transaminases, albumin, prothrombin time, and serologies for hepatitis A, C, delta, and HIV. Hepatitis B specific laboratory tests include hepatitis B surface antigen, e antigen, anti-HBe, and hepatitis B viral DNA. A serum alpha fetoprotein and ultrasound or CT should be obtained every 6-12 months to screen for hepatocellular carcinoma. Liver biopsy is not routinely necessary in the diagnosis and management of chronic HBV.20.”
Included in this issue also is a chart of FDA approved medications for HBV prevention and treatment
IDCR wraps up with a review of the 2008 conference on retroviruses and opportunistic infections .
Click here to read the full newsletter. .
IN CASE YOU MISSED IT